title: Immunohemolytic anemia following oxaliplatin administration.
authors.forename: C
authors.initials: C
authors.lastname: Garufi
authors.forename: S
authors.initials: S
authors.lastname: Vaglio
authors.forename: S
authors.initials: S
authors.lastname: Brienza
authors.forename: L
authors.initials: L
authors.lastname: Conti
authors.forename: R M
authors.initials: RM
authors.lastname: D'Attino
authors.forename: G
authors.initials: G
authors.lastname: Girelli
authors.forename: E
authors.initials: E
authors.lastname: Terzoli
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000077150:Oxaliplatin
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin